TRIM
Thompson Rubinstein Investment Management Portfolio holdings
AUM
$311M
This Quarter Return
+7.12%
1 Year Return
+11.73%
3 Year Return
+42.84%
5 Year Return
+48.8%
10 Year Return
–
AUM
$304M
AUM Growth
+$304M
(+6%)
Cap. Flow
-$1.59M
Cap. Flow
% of AUM
-0.52%
Top 10 Holdings %
Top 10 Hldgs %
39.76%
Holding
80
New
1
Increased
8
Reduced
37
Closed
2
Top Buys
| 1 |
CELG
Celgene Corp
CELG
|
$1.54M |
| 2 |
Novartis
NVS
|
$487K |
| 3 |
CVS Health
CVS
|
$167K |
| 4 |
GE Aerospace
GE
|
$155K |
| 5 |
Schlumberger
SLB
|
$94.1K |
Top Sells
| 1 |
Bruker
BRKR
|
$967K |
| 2 |
SVU
SUPERVALU Inc.
SVU
|
$708K |
| 3 |
DO
Diamond Offshore Drilling
DO
|
$298K |
| 4 |
LVLT
Level 3 Communications Inc
LVLT
|
$282K |
| 5 |
Intel
INTC
|
$148K |
Sector Composition
| 1 | Healthcare | 27.94% |
| 2 | Industrials | 23% |
| 3 | Technology | 16.75% |
| 4 | Energy | 9.09% |
| 5 | Consumer Staples | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Caterpillar
CAT
$196B
| $1.5M | 0.49% |
9,488
-635
| -6% | -$100K |
|
52
Transocean
RIG
$2.86B
| $1.38M | 0.45% |
128,893
-6,098
| -5% | -$65.1K |
|
53
Devon Energy
DVN
$22.9B
| $1.34M | 0.44% |
32,300
-175
| -0.5% | -$7.24K |
|
54
US Bancorp
USB
$76B
| $1.29M | 0.42% |
24,037
| – | – |
|
|
FLOW
55
DELISTED
SPX FLOW, Inc.
FLOW
| $1.27M | 0.42% |
26,722
| – | – |
|
56
SPX Corp
SPXC
$9.25B
| $1.18M | 0.39% |
37,727
| – | – |
|
57
Verizon
VZ
$186B
| $1.02M | 0.33% |
19,186
+540
| +3% | +$28.6K |
|
58
AT&T
T
$209B
| $1.01M | 0.33% |
26,047
-200
| -0.8% | -$7.78K |
|
|
BIVV
59
DELISTED
Bioverativ Inc. Common Stock
BIVV
| $892K | 0.29% |
16,538
-100
| -0.6% | -$5.39K |
|
60
BorgWarner
BWA
$9.25B
| $741K | 0.24% |
14,508
-127
| -0.9% | -$6.49K |
|
|
CDK
61
DELISTED
CDK Global, Inc.
CDK
| $720K | 0.24% |
10,095
-85
| -0.8% | -$6.06K |
|
62
JPMorgan Chase
JPM
$829B
| $669K | 0.22% |
6,255
| – | – |
|
63
Merck
MRK
$210B
| $609K | 0.2% |
10,829
-300
| -3% | -$16.9K |
|
64
Travelers Companies
TRV
$61.1B
| $608K | 0.2% |
4,479
| – | – |
|
65
Bristol-Myers Squibb
BMY
$96B
| $588K | 0.19% |
9,600
| – | – |
|
66
Varex Imaging
VREX
$480M
| $536K | 0.18% |
13,350
-650
| -5% | -$26.1K |
|
67
Marsh & McLennan
MMC
$101B
| $533K | 0.18% |
6,543
| – | – |
|
|
AGN
68
DELISTED
Allergan plc
AGN
| $482K | 0.16% |
2,946
| – | – |
|
69
Johnson Controls International
JCI
$69.9B
| $436K | 0.14% |
11,432
| – | – |
|
70
RTX Corp
RTX
$212B
| $408K | 0.13% |
3,200
| – | – |
|
71
West Pharmaceutical
WST
$17.8B
| $386K | 0.13% |
3,907
-93
| -2% | -$9.19K |
|
72
ING
ING
$70.3B
| $376K | 0.12% |
20,388
| – | – |
|
73
Oracle
ORCL
$635B
| $374K | 0.12% |
7,900
| – | – |
|
74
Edwards Lifesciences
EW
$47.8B
| $328K | 0.11% |
2,906
| – | – |
|
75
Cabot Corp
CBT
$4.34B
| $296K | 0.1% |
4,800
| – | – |
|